No Cancer Signal Detected Keith Testimonial

No Cancer Signal Detected

"Early detection is key to trying to figure out what you can do and do it early." - Keith

Keith’s Experience with the Galleri test

[Keith] Well, life in Oregon for a retiree can be quite exciting, but a typical day will be board meetings. A typical day will be spending time with the family. In fact, I don't know how I had found enough time to have a job.

With an engineering background, I love to see how things work. And the medical world is unbelievable.

I had 30 wonderful years with Intel. The governor appointed me to the board of OSU and that was my first introduction into healthcare and what a hospital corporation is like.

That's also where we got involved with the Knight Cancer Institute, a major research facility that would focus on early detection of cancer.

“ Cancer is a despicable disease. ”

It's had a major influence on our society, a major influence on the healthcare facilities, and it destroys families and it destroys lives.

“ Early detection is key to trying to figure out what you can do and do it early. ”

When I heard about the Galleri test, which is a multicancer early detection test, I said,

“ This is wonderful. ”

Found out that this was a simple blood draw similar to what you get every year at your annual physical. That it had the capability of identifying over 50 different cancers and in many cases identifying what organ those cancers may be originating in.

After I heard all that, I said,

“ I've got to participate in this. ”

A couple weeks later, I got the results of No Signal Detected.

And I think about it now in our lives and my grandkids' lives as to having a test like this is a wonderful opportunity to catch things early.

“ I really hope that this becomes a normal part of medical care. ”

And that we can use it in the future for future generations.

Based on a clinical study of people ages 50 to 79 around 1% are expected to receive a Cancer Signal Detected result, which includes a predicted Cancer Signal Origin. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis.

The overall sensitivity in study participants with liver/bile duct cancer was 93.5% (100% for stage I, 70.0% stage II, 100% stage III, 100% stage IV).

Have more questions?

Please answer the following questions to fill in the appropriate form.

GRAIL Customer Service
(833) 694‑2553
customerservice@grail.com

To report suspected Adverse Events or product issues, contact GRAIL Customer Service.

What describes you best?

I am a Patient

I am a Healthcare Provider

I represent a Health System or Provider Network

I represent an Employer

I represent a Firefighter or First Responder organization
What are you looking for?

I need customer support

I have questions about my bill

I'd like to learn more about Galleri

I am new to Galleri and have some questions

I am ready to get started with Galleri

I need customer support

I'd like to receive Galleri email updates

I'd like to speak with someone

I want to speak with someone

I'd like to receive Galleri email updates

I want to speak with someone
Fill in the form

First name

Last name

How can we help you?

Message

Email address

Phone number

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Billing Support

This form is for billing questions only. If you need general customer support, please choose one of the other forms or use the chat option at the bottom of your screen.

First name

Last name

Email address

Company name (if applicable)

What do you need help with?

Message (DO NOT include personal health or payment information)

By submitting this form, you agree to GRAIL’s use of this information to contact you. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Learn more about the Galleri test - What is Galleri?

First name

Last name

Email address

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

First name

Last name

Practice name

Email address

Phone number

Preferred contact method

NPI (10 digits only)

Practice zip code

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Please login to the Provider Portal if you are already an ordering provider.

Provider first name

Provider last name

Email address

Phone number

NPI (10 digits only)

Practice zip code

Practice name

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

First name

Last name

Email address

Phone number

City

State

Practice zip code

How can we help you?

Practice name

Message

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

First name

Last name

Email address

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Health System or Provider Network

If you are a concierge, private, or group practice provider, complete this form instead.

First name

Last name

Health system or Provider network name

Title

Department

Work email address

Phone number

State

Zip code

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Do you represent a first responder or firefighter organization? Use this form instead.

First name

Last name

Email address

Phone number

Company name

Title

Number of employees

Address

City

Zip code

Corporate headquarters location

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

First name

Last name

Work email address

State

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

Fill out the form to download a copy of the full case study.

This form is meant for firefighter and first responder organizations only

First name

Last name

Organization

Email address

Zip code

By submitting this form, you agree to GRAIL’s use of this information to contact you, including for marketing purposes. Please do not include any sensitive or confidential information, including health information. For more information, please refer to our privacy notice.

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes

Demonstrated performance across ~400,000 participants

NHS-Galleri and PATHFINDER 2 trial results

No Cancer Signal Detected

Have more questions?

What describes you best?

What are you looking for?

Fill in the form

Billing Support

Health System or Provider Network

Fill out the form to download a copy of the full case study.

Important Safety Information

Laboratory/Test Information